Cargando…
Therapeutic inhibition of CXCR1/2: where do we stand?
Mounting experimental evidence from in vitro and in vivo animal studies points to an essential role of the CXCL8-CXCR1/2 axis in neutrophils in the pathophysiology of inflammatory and autoimmune diseases. In addition, the pathogenetic involvement of neutrophils and the CXCL8-CXCR1/2 axis in cancer p...
Autores principales: | Sitaru, Sebastian, Budke, Agnes, Bertini, Riccardo, Sperandio, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227827/ https://www.ncbi.nlm.nih.gov/pubmed/37249756 http://dx.doi.org/10.1007/s11739-023-03309-5 |
Ejemplares similares
-
Where Do We Stand?
Publicado: (1891) -
Spinal Muscular Atrophy Therapeutics: Where do we Stand?
por: d’Ydewalle, Constantin, et al.
Publicado: (2015) -
Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016) -
Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017) -
ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)